ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Glaxosmithkline LLC

Official 2024 U.S. DOL Form 5500 summary for Glaxosmithkline LLC (Gsk 401(k) Plan · EIN 23-1099050 · PN 002): $8.79B net assets, 12,254 active participants, and $9.01 per $10,000 (9.01 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorGlaxosmithkline LLC
Filing IdentifierGsk 401(k) Plan · EIN 23-1099050 · PN 002
Plan Category & State401(k) Defined Contribution (PA)
Asset-Size Peer Cohort>$1B
Plan Net Assets (2024)$8.79B
Active Participants12,254
Direct Admin Fee Rate$9.01 per $10,000 (9.01 bps)
Cohort Peer Median$4.40 per $10,000 (4.40 bps)
Primary Recordkeeper / ProviderAlight Solutions
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI

Cross-Agency Entity Graph

Related Filings Across Meru Platforms

Verified federal filings reconciled for GSK across sibling Meru AI platforms.